Top Industry Leaders in the Cardiac Tamponade Market
Latest Cardiac Tamponade Companies Updates:
This October 2023 development signifies the potential of Abbott's CardioFlow™ System to enhance real-time monitoring and fluid management in patients with cardiac tamponade, potentially improving outcomes.
This January 2024 approval expands access to LivaNova's PERCUSAFT™ Drainage System in Europe, offering healthcare professionals a minimally invasive option for pericardial effusion drainage, a common cause of cardiac tamponade.
This research presented at a major cardiology conference in November 2023 showcases the effectiveness of Boston Scientific's Brockenbrough Septal Dilator in facilitating transseptal access for cardiac tamponade drainage, potentially leading to wider adoption of this technique.
This innovative platform integrates advanced artificial intelligence capabilities into echocardiography systems, potentially aiding in rapid and accurate diagnosis of cardiac tamponade in clinical settings.
List of Cardiac Tamponade Key companies in the market:
- Medtronic, Inc.,
- Hitachi, Ltd.,
- General Electric Company,
- Koninklijke Philips N.V.,
- Siemens Healthcare Private Limited,
- Boston Scientific Corporation,
- Toshiba Medical Systems Corporation,
- St. Jude Medical Inc.,
